KLI

Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib

Metadata Downloads
Publisher
BREAST CANCER RESEARCH AND TREATMENT
Language
영어
ISSN
0167-6806
Citation Volume
184
Citation Number
3
Citation Start Page
743
Citation End Page
753
Appears in Collections:
Medicine > Medicine
공개 및 라이선스
  • 공개 구분공개
파일 목록
  • 관련 파일이 존재하지 않습니다.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.